NanoVibronix effects 1-for-10 reverse stock split effective Aug 11, 2025

ENvue Medical, Inc.

Reverse stock split reduces outstanding shares from 7,968,868 to ~796,887.
Effective 4:05 p.m. ET on Aug 11, 2025; split-adjusted trading begins Aug 12, 2025.
No fractional shares issued; any fractional shares rounded up to whole number.
Adjustments made to equity awards, warrants, and convertible securities proportionally.
New CUSIP 63008J884; trading symbol remains NAOV on Nasdaq Capital Market.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.